Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

[Reliability and safety of intravitreal Ozurdex injections. The ZERO study].

Schmitz K, Maier M, Clemens CR, Höhn F, Wachtlin J, Lehmann F, Bertelmann T, Rüdiger K, Horn M, Bezatis A, Spital G, Meyer CH; German Retinal Vein Occlusion Group..

Ophthalmologe. 2014 Jan;111(1):44-52. doi: 10.1007/s00347-012-2737-2. German.

PMID:
23559321
3.

SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.

Coscas G, Coscas F, Zucchiatti I, Glacet-Bernard A, Soubrane G, Souïed E.

Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.

PMID:
21500185
4.

Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.

Ferrini W, Ambresin A.

Klin Monbl Augenheilkd. 2013 Apr;230(4):423-6. doi: 10.1055/s-0032-1328388.

PMID:
23629796
5.

[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].

Brunner M, Haueter I, Valmaggia C.

Klin Monbl Augenheilkd. 2013 Apr;230(4):396-400. doi: 10.1055/s-0032-1328365. German.

PMID:
23629790
6.

OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.

Reid GA, Sahota DS, Sarhan M.

Retina. 2015 Aug;35(8):1647-55. doi: 10.1097/IAE.0000000000000524.

PMID:
25932545
7.

Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion.

Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G, Parravano MC, Udaondo P, Moisseiev E, Soubrane G, Yatziv Y, Loewenstein A.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):1-9. doi: 10.5301/ejo.5000376.

8.

Accidental injections of dexamethasone intravitreal implant (Ozurdex) into the crystalline lens.

Coca-Robinot J, Casco-Silva B, Armadá-Maresca F, García-Martínez J.

Eur J Ophthalmol. 2014 Jul-Aug;24(4):633-6. doi: 10.5301/ejo.5000439.

PMID:
24519506
9.

EVALUATION OF MULTIPLE DEXAMETHASONE INTRAVITREAL IMPLANTS IN PATIENTS WITH MACULAR EDEMA ASSOCIATED WITH RETINAL VEIN OCCLUSION.

Bakri SJ, Omar AF, Iezzi R, Kapoor KG.

Retina. 2016 Mar;36(3):552-7. doi: 10.1097/IAE.0000000000000750.

PMID:
26418442
10.

Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.

Stepanov A, Codenotti M, Ramoni A, Prati M, Jiraskova N, Rozsival P, Bandello F.

Eur J Ophthalmol. 2016 Apr 12;26(3):e52-4. doi: 10.5301/ejo.5000715.

PMID:
26615950
12.
13.

Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group..

Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032.

PMID:
20417567
14.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732.

PMID:
22739239
15.

Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.

Meyer LM, Schönfeld CL.

J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):560-5. doi: 10.1089/jop.2012.0253.

PMID:
23480270
16.

Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.

Mazzarella S, Mateo C, Freixes S, Burés-Jelstrup A, Rios J, Navarro R, García-Arumí J, Corcóstegui B, Arrondo E.

Ophthalmic Res. 2015;54(3):143-9. doi: 10.1159/000438759.

PMID:
26394206
17.

Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.

Singer MA, Bell DJ, Woods P, Pollard J, Boord T, Herro A, Porbandarwalla S.

Retina. 2012 Jul;32(7):1289-94. doi: 10.1097/IAE.0b013e318242b838.

PMID:
22466480
18.

Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.

Adán A, Pelegrín L, Rey A, Llorenç V, Mesquida M, Molins B, Ríos J, Keller J.

Retina. 2013 Jul-Aug;33(7):1435-40. doi: 10.1097/IAE.0b013e31827e247b.

PMID:
23514796
19.

Long-term evaluation of patients treated with dexamethasone intravitreal implant for macular edema due to retinal vein occlusion.

Moisseiev E, Goldstein M, Waisbourd M, Barak A, Loewenstein A.

Eye (Lond). 2013 Jan;27(1):65-71. doi: 10.1038/eye.2012.226.

20.

Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results.

Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, Whitcup SM; Ozurdex GENEVA Study Group., Li J.

Ophthalmology. 2011 Dec;118(12):2453-60. doi: 10.1016/j.ophtha.2011.05.014.

PMID:
21764136

Supplemental Content

Support Center